☰ Chemistry Tree

Walter H. Moos, Ph.D.

Affiliations:	1982-1991	Pharmaceutical Research Division	Warner-Lambert/Parke-Davis
	1990-1992	Medicinal Chemistry	University of Michigan, Ann Arbor, Ann Arbor, MI
	1991-1997	Technologies Division	Chiron
	1992-	Pharmaceutical Chemistry	University of California, San Francisco, San Francisco, CA
	1997-2004		MitoKor
	2005-2016	Biosciences Division	Stanford Research Institute (SRI International)
	2007-2015	Integrated Science and Technology	James Madison University, Harrisonburg, VA, United States
	2016-2020		ShangPharma Innovation
	2018-		Pandect Bioventures

Area:

drug discovery

Website:

http://www.linkedin.com/in/walter-h-moos-7710804

Google:

Bio:

Mean distance: (not calculated yet)

Tree Publications Similar researchers PubMed Report error

Parents

grad student

1982

Children

Timothy W. Hepburn	post-doc		University of Michigan
Thomas Renau	post-doc		University of Michigan
Amol Anant Kulkarni	research scientist	2014-2015	Howard University

Collaborators

Douglas V. Faller	collaborator		Boston University & School of Medicine (Microtree)
Michael H. Irwin	collaborator		Auburn University
Krishna Kodukula	collaborator		ShangPharma Innovation and Stanford Research Institute
Susan M. Miller	collaborator		UCSF
Carl A. Pinkert	collaborator		Auburn University (Cell Biology Tree)
Kosta Steliou	collaborator		Boston University

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Moos WH, Faller DV, Glavas IP, et al. (2023) Epilepsy: Mitochondrial Connections to the 'Sacred' Disease. Mitochondrion
Moos WH, Faller DV, Glavas IP, et al. (2022) Treatment and Prevention of Pathological Mitochondrial Dysfunction in Retinal Degeneration and in Photoreceptor Injury. Biochemical Pharmacology. 115168
Moos WH, Faller DV, Glavas IP, et al. (2021) Pathogenic mitochondrial dysfunction and metabolic abnormalities. Biochemical Pharmacology. 193: 114809
Dua N, Fyrenius M, Johnson DL, et al. (2021) Are in-person scientific conferences dead or alive? Faseb Bioadvances. 3: 420-427
Moos WH, Faller DV, Glavas IP, et al. (2020) Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs. Bioresearch Open Access. 9: 94-105
Moos WH, Faller DV, Glavas IP, et al. (2019) Epigenetic treatment of dermatologic disorders Drug Development Research. 80: 702-713
Angell Y, Holford M, Moos WH. (2018) Peptides 2020: A Clear Therapeutic Vision. Protein and Peptide Letters. 25: 1042-1043
Angell YM, Moos WH. (2018) Building on Success: A Bright Future for Peptide Therapeutics. Protein and Peptide Letters
Moos WH, Faller DV, Glavas IP, et al. (2018) A New Approach to Treating Neurodegenerative Otologic Disorders. Bioresearch Open Access. 7: 107-115
Moos WH, Faller DV, Glavas IP, et al. (2017) Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future. Bioresearch Open Access. 6: 169-181

See more...